Department of Pediatric Nephrology, Amsterdam UMC, Amsterdam, The Netherlands.
Department of Genetics, Center for Molecular Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Clin J Am Soc Nephrol. 2020 Dec 31;16(1):128-137. doi: 10.2215/CJN.14661119. Epub 2020 Apr 20.
Revolutions in genetics, epigenetics, and bioinformatics are currently changing the outline of diagnostics and clinical medicine. From a nephrologist's perspective, individuals with congenital anomalies of the kidney and urinary tract (CAKUT) are an important patient category: not only is CAKUT the predominant cause of kidney failure in children and young adults, but the strong phenotypic and genotypic heterogeneity of kidney and urinary tract malformations has hampered standardization of clinical decision making until now. However, patients with CAKUT may benefit from precision medicine, including an integrated diagnostics trajectory, genetic counseling, and personalized management to improve clinical outcomes of developmental kidney and urinary tract defects. In this review, we discuss the present understanding of the molecular etiology of CAKUT and the currently available genome diagnostic modalities in the clinical care of patients with CAKUT. Finally, we discuss how clinical integration of findings from large-scale genetic, epigenetic, and gene-environment interaction studies may improve the prognosis of all individuals with CAKUT.
遗传学、表观遗传学和生物信息学的革命正在改变诊断学和临床医学的格局。从肾脏病学家的角度来看,先天性肾和尿路畸形(CAKUT)患者是一个重要的患者群体:CAKUT 不仅是儿童和青年肾衰竭的主要原因,而且肾脏和尿路畸形的强烈表型和基因型异质性一直阻碍着临床决策的标准化。然而,CAKUT 患者可能受益于精准医学,包括综合诊断轨迹、遗传咨询和个性化管理,以改善发育性肾脏和尿路缺陷的临床结果。在这篇综述中,我们讨论了 CAKUT 的分子病因学的现有认识,以及目前在 CAKUT 患者的临床护理中可用的基因组诊断方式。最后,我们讨论了如何将大规模遗传、表观遗传和基因-环境相互作用研究的结果与临床相结合,以改善所有 CAKUT 患者的预后。